CRANE NXT CO (CXT) Fundamental Analysis & Valuation

NYSE:CXTUS2244411052

Current stock price

41.4 USD
+1.21 (+3.01%)
At close:
41.4 USD
0 (0%)
After Hours:

This CXT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. CXT Profitability Analysis

1.1 Basic Checks

  • In the past year CXT was profitable.
  • In the past year CXT had a positive cash flow from operations.
  • CXT had positive earnings in each of the past 5 years.
  • CXT had a positive operating cash flow in each of the past 5 years.
CXT Yearly Net Income VS EBIT VS OCF VS FCFCXT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • With a decent Return On Assets value of 4.66%, CXT is doing good in the industry, outperforming 70.16% of the companies in the same industry.
  • CXT has a Return On Equity of 11.58%. This is in the better half of the industry: CXT outperforms 75.00% of its industry peers.
  • CXT's Return On Invested Capital of 7.93% is fine compared to the rest of the industry. CXT outperforms 75.81% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CXT is above the industry average of 8.20%.
Industry RankSector Rank
ROA 4.66%
ROE 11.58%
ROIC 7.93%
ROA(3y)7.07%
ROA(5y)6.96%
ROE(3y)16.13%
ROE(5y)16.85%
ROIC(3y)11.93%
ROIC(5y)11.12%
CXT Yearly ROA, ROE, ROICCXT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • CXT has a better Profit Margin (8.76%) than 79.84% of its industry peers.
  • In the last couple of years the Profit Margin of CXT has grown nicely.
  • CXT's Operating Margin of 15.91% is amongst the best of the industry. CXT outperforms 90.32% of its industry peers.
  • CXT's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 42.48%, CXT is in the better half of the industry, outperforming 72.58% of the companies in the same industry.
  • CXT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.91%
PM (TTM) 8.76%
GM 42.48%
OM growth 3Y-6.41%
OM growth 5Y12.78%
PM growth 3Y-16.95%
PM growth 5Y5.97%
GM growth 3Y-3.13%
GM growth 5Y3.98%
CXT Yearly Profit, Operating, Gross MarginsCXT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 10 20 30 40

3

2. CXT Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CXT is creating some value.
  • CXT has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, CXT has less shares outstanding
  • The debt/assets ratio for CXT is higher compared to a year ago.
CXT Yearly Shares OutstandingCXT Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
CXT Yearly Total Debt VS Total AssetsCXT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • CXT has an Altman-Z score of 1.83. This is not the best score and indicates that CXT is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 1.83, CXT is not doing good in the industry: 65.32% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of CXT is 5.75, which is a neutral value as it means it would take CXT, 5.75 years of fcf income to pay off all of its debts.
  • CXT's Debt to FCF ratio of 5.75 is in line compared to the rest of the industry. CXT outperforms 58.06% of its industry peers.
  • CXT has a Debt/Equity ratio of 0.91. This is a neutral value indicating CXT is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.91, CXT is doing worse than 85.48% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 5.75
Altman-Z 1.83
ROIC/WACC0.84
WACC9.42%
CXT Yearly LT Debt VS Equity VS FCFCXT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 1.50 indicates that CXT should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.50, CXT is doing worse than 76.61% of the companies in the same industry.
  • CXT has a Quick Ratio of 1.20. This is a normal value and indicates that CXT is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.20, CXT is not doing good in the industry: 66.94% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.2
CXT Yearly Current Assets VS Current LiabilitesCXT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

4

3. CXT Growth Analysis

3.1 Past

  • The earnings per share for CXT have decreased by -4.92% in the last year.
  • Measured over the past 5 years, CXT shows a small growth in Earnings Per Share. The EPS has been growing by 1.12% on average per year.
  • Looking at the last year, CXT shows a quite strong growth in Revenue. The Revenue has grown by 11.43% in the last year.
  • Measured over the past years, CXT shows a decrease in Revenue. The Revenue has been decreasing by -9.71% on average per year.
EPS 1Y (TTM)-4.92%
EPS 3Y-19.21%
EPS 5Y1.12%
EPS Q2Q%5.83%
Revenue 1Y (TTM)11.43%
Revenue growth 3Y7.33%
Revenue growth 5Y-9.71%
Sales Q2Q%19.49%

3.2 Future

  • Based on estimates for the next years, CXT will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.32% on average per year.
  • Based on estimates for the next years, CXT will show a small growth in Revenue. The Revenue will grow by 4.29% on average per year.
EPS Next Y6.3%
EPS Next 2Y8.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.31%
Revenue Next 2Y5.29%
Revenue Next 3Y4.29%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CXT Yearly Revenue VS EstimatesCXT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
CXT Yearly EPS VS EstimatesCXT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

8

4. CXT Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 10.20 indicates a reasonable valuation of CXT.
  • 92.74% of the companies in the same industry are more expensive than CXT, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of CXT to the average of the S&P500 Index (26.21), we can say CXT is valued rather cheaply.
  • A Price/Forward Earnings ratio of 9.59 indicates a reasonable valuation of CXT.
  • 91.94% of the companies in the same industry are more expensive than CXT, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 23.13. CXT is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.2
Fwd PE 9.59
CXT Price Earnings VS Forward Price EarningsCXT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • CXT's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CXT is cheaper than 89.52% of the companies in the same industry.
  • CXT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CXT is cheaper than 90.32% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.99
EV/EBITDA 8.32
CXT Per share dataCXT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • CXT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of CXT may justify a higher PE ratio.
PEG (NY)1.62
PEG (5Y)9.1
EPS Next 2Y8.32%
EPS Next 3YN/A

6

5. CXT Dividend Analysis

5.1 Amount

  • CXT has a Yearly Dividend Yield of 1.75%.
  • Compared to an average industry Dividend Yield of 0.47, CXT pays a better dividend. On top of this CXT pays more dividend than 93.55% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, CXT has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.75%

5.2 History

  • On average, the dividend of CXT grows each year by 6.42%, which is quite nice.
  • CXT has been paying a dividend for at least 10 years, so it has a reliable track record.
  • CXT has decreased its dividend recently.
Dividend Growth(5Y)6.42%
Div Incr Years1
Div Non Decr Years1
CXT Yearly Dividends per shareCXT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • CXT pays out 26.88% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of CXT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP26.88%
EPS Next 2Y8.32%
EPS Next 3YN/A
CXT Yearly Income VS Free CF VS DividendCXT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
CXT Dividend Payout.CXT Dividend Payout, showing the Payout Ratio.CXT Dividend Payout.PayoutRetained Earnings

CXT Fundamentals: All Metrics, Ratios and Statistics

CRANE NXT CO

NYSE:CXT (4/6/2026, 7:31:20 PM)

After market: 41.4 0 (0%)

41.4

+1.21 (+3.01%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-11
Earnings (Next)05-05
Inst Owners113.86%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner Change5.59%
Market Cap2.38B
Revenue(TTM)1.66B
Net Income(TTM)145.10M
Analysts81.82
Price Target91.36 (120.68%)
Short Float %12.25%
Short Ratio7.87
Dividend
Industry RankSector Rank
Dividend Yield 1.75%
Yearly Dividend0.68
Dividend Growth(5Y)6.42%
DP26.88%
Div Incr Years1
Div Non Decr Years1
Ex-Date02-27
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.06%
Min EPS beat(2)0.03%
Max EPS beat(2)0.1%
EPS beat(4)4
Avg EPS beat(4)1.37%
Min EPS beat(4)0.03%
Max EPS beat(4)3.95%
EPS beat(8)6
Avg EPS beat(8)0.66%
EPS beat(12)10
Avg EPS beat(12)5.62%
EPS beat(16)13
Avg EPS beat(16)5.54%
Revenue beat(2)2
Avg Revenue beat(2)3.34%
Min Revenue beat(2)1.89%
Max Revenue beat(2)4.78%
Revenue beat(4)3
Avg Revenue beat(4)1.73%
Min Revenue beat(4)-2.45%
Max Revenue beat(4)4.78%
Revenue beat(8)4
Avg Revenue beat(8)0.72%
Revenue beat(12)7
Avg Revenue beat(12)1.19%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-3.09%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-35.37%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.43%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.26%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-0.4%
Valuation
Industry RankSector Rank
PE 10.2
Fwd PE 9.59
P/S 1.44
P/FCF 11.99
P/OCF 9.85
P/B 1.9
P/tB N/A
EV/EBITDA 8.32
EPS(TTM)4.06
EY9.81%
EPS(NY)4.32
Fwd EY10.42%
FCF(TTM)3.45
FCFY8.34%
OCF(TTM)4.2
OCFY10.16%
SpS28.84
BVpS21.81
TBVpS-8.15
PEG (NY)1.62
PEG (5Y)9.1
Graham Number44.64
Profitability
Industry RankSector Rank
ROA 4.66%
ROE 11.58%
ROCE 10.34%
ROIC 7.93%
ROICexc 8.69%
ROICexgc 29.25%
OM 15.91%
PM (TTM) 8.76%
GM 42.48%
FCFM 11.97%
ROA(3y)7.07%
ROA(5y)6.96%
ROE(3y)16.13%
ROE(5y)16.85%
ROIC(3y)11.93%
ROIC(5y)11.12%
ROICexc(3y)13.26%
ROICexc(5y)12.51%
ROICexgc(3y)48.49%
ROICexgc(5y)45.78%
ROCE(3y)15.59%
ROCE(5y)14.95%
ROICexgc growth 3Y-18.71%
ROICexgc growth 5Y16.5%
ROICexc growth 3Y-13.43%
ROICexc growth 5Y8.62%
OM growth 3Y-6.41%
OM growth 5Y12.78%
PM growth 3Y-16.95%
PM growth 5Y5.97%
GM growth 3Y-3.13%
GM growth 5Y3.98%
F-Score4
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 5.75
Debt/EBITDA 3.08
Cap/Depr 40.53%
Cap/Sales 2.61%
Interest Coverage 4.74
Cash Conversion 65.25%
Profit Quality 136.66%
Current Ratio 1.5
Quick Ratio 1.2
Altman-Z 1.83
F-Score4
WACC9.42%
ROIC/WACC0.84
Cap/Depr(3y)44.3%
Cap/Depr(5y)36.54%
Cap/Sales(3y)2.63%
Cap/Sales(5y)2.17%
Profit Quality(3y)119.51%
Profit Quality(5y)128.53%
High Growth Momentum
Growth
EPS 1Y (TTM)-4.92%
EPS 3Y-19.21%
EPS 5Y1.12%
EPS Q2Q%5.83%
EPS Next Y6.3%
EPS Next 2Y8.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.43%
Revenue growth 3Y7.33%
Revenue growth 5Y-9.71%
Sales Q2Q%19.49%
Revenue Next Year6.31%
Revenue Next 2Y5.29%
Revenue Next 3Y4.29%
Revenue Next 5YN/A
EBIT growth 1Y-14.09%
EBIT growth 3Y0.45%
EBIT growth 5Y1.82%
EBIT Next Year18.85%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y17.55%
FCF growth 3Y-11.36%
FCF growth 5Y-6.44%
OCF growth 1Y12.8%
OCF growth 3Y-7.59%
OCF growth 5Y-4.84%

CRANE NXT CO / CXT Fundamental Analysis FAQ

What is the fundamental rating for CXT stock?

ChartMill assigns a fundamental rating of 6 / 10 to CXT.


Can you provide the valuation status for CRANE NXT CO?

ChartMill assigns a valuation rating of 8 / 10 to CRANE NXT CO (CXT). This can be considered as Undervalued.


How profitable is CRANE NXT CO (CXT) stock?

CRANE NXT CO (CXT) has a profitability rating of 8 / 10.


What is the financial health of CRANE NXT CO (CXT) stock?

The financial health rating of CRANE NXT CO (CXT) is 3 / 10.


What is the earnings growth outlook for CRANE NXT CO?

The Earnings per Share (EPS) of CRANE NXT CO (CXT) is expected to grow by 6.3% in the next year.